A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma

作者:Rosenthal Allison; Kumar Shaji; Hofmeister Craig; Laubach Jacob; Vij Ravi; Dueck Amylou; Gano Katherine; Stewart A Keith*
来源:British Journal of Haematology, 2016, 174(2): 323-325.
DOI:10.1111/bjh.13765